Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

Study on the herb-herb interaction of Danqi Tongmai Tablet based on the pharmacokinetics of twelve notoginsenoides in acute myocardial ischemia and sham rats.

Zhi H, Deng Y, Yan B, Li Z, Han S, Zhang Y, Hou J, Wu W, Guo D.

J Pharm Biomed Anal. 2019 Mar 20;166:52-65. doi: 10.1016/j.jpba.2018.12.043. Epub 2018 Dec 29.

PMID:
30609394
2.

Effects of Panax Notoginseng Saponins on Esterases Responsible for Aspirin Hydrolysis In Vitro.

Sun Z, Wu Y, Liu S, Hu S, Zhao B, Li P, Du S.

Int J Mol Sci. 2018 Oct 12;19(10). pii: E3144. doi: 10.3390/ijms19103144.

3.

Traditional Chinese medicine: herb-drug interactions with aspirin.

Lim JW, Chee SX, Wong WJ, He QL, Lau TC.

Singapore Med J. 2018 May;59(5):230-239. doi: 10.11622/smedj.2018051. Review.

4.

Effect of aspirin on the pharmacokinetics and absorption of panax notoginseng saponins.

Tian Z, Pang H, Zhang Q, Du S, Lu Y, Zhang L, Bai J, Li P, Li D, Zhao M, Chen X.

J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Feb 1;1074-1075:25-33. doi: 10.1016/j.jchromb.2017.12.033. Epub 2018 Jan 2.

PMID:
29329092
5.

Herbal products containing Hibiscus sabdariffa L., Crataegus spp., and Panax spp.: Labeling and safety concerns.

Nunes MA, Rodrigues F, Alves RC, Oliveira MBPP.

Food Res Int. 2017 Oct;100(Pt 1):529-540. doi: 10.1016/j.foodres.2017.07.031. Epub 2017 Jul 19.

PMID:
28873717
6.

Global deregulation of ginseng products may be a safety hazard to warfarin takers: solid evidence of ginseng-warfarin interaction.

Dong H, Ma J, Li T, Xiao Y, Zheng N, Liu J, Gao Y, Shao J, Jia L.

Sci Rep. 2017 Jul 19;7(1):5813. doi: 10.1038/s41598-017-05825-9.

7.

Pharmacokinetic Drug Interactions with Panax ginseng.

Ramanathan MR, Penzak SR.

Eur J Drug Metab Pharmacokinet. 2017 Aug;42(4):545-557. doi: 10.1007/s13318-016-0387-5. Review.

PMID:
27864798
8.

Clinically Relevant Pharmacokinetic Herb-drug Interactions in Antiretroviral Therapy.

Fasinu PS, Gurley BJ, Walker LA.

Curr Drug Metab. 2015;17(1):52-64. Review.

PMID:
26526838
9.

[Advances in the study of enzymes and transporters-mediated pharmacokinetic mechanism for herb-drug interaction].

Liu Q, Liu KX.

Yao Xue Xue Bao. 2015 Apr;50(4):406-12. Review. Chinese.

PMID:
26223121
10.

Effects of notoginsenoside R1 on CYP1A2, CYP2C11, CYP2D1, and CYP3A1/2 activities in rats by cocktail probe drugs.

Yin S, Cheng Y, Li T, Dong M, Zhao H, Liu G.

Pharm Biol. 2016;54(2):231-6. doi: 10.3109/13880209.2015.1029051. Epub 2015 Apr 2.

PMID:
25834921
11.

Drug reaction with eosinophilia and systemic symptoms syndrome probably induced by a lamotrigine-ginseng drug interaction.

Myers AP, Watson TA, Strock SB.

Pharmacotherapy. 2015 Mar;35(3):e9-e12. doi: 10.1002/phar.1550. Epub 2015 Mar 10.

PMID:
25756365
12.

Interaction between warfarin and Chinese herbal medicines.

Chua YT, Ang XL, Zhong XM, Khoo KS.

Singapore Med J. 2015 Jan;56(1):11-8. Review.

13.

Negligible pharmacokinetic interaction of red ginseng and antihypertensive agent amlodipine in Sprague-Dawley rats.

Ryu SH, Kim JW, Kim YS, Lee SH, Cho YB, Lee HK, Kim YG, Jeong WS, Kim KB.

J Toxicol Environ Health A. 2014;77(22-24):1372-83. doi: 10.1080/15287394.2014.951594.

PMID:
25343287
14.

In vivo distribution and pharmacokinetics of multiple active components from Danshen and Sanqi and their combination via inner ear administration.

Long W, Zhang SC, Wen L, Mu L, Yang F, Chen G.

J Ethnopharmacol. 2014 Oct 28;156:199-208. doi: 10.1016/j.jep.2014.08.041. Epub 2014 Sep 16.

PMID:
25218322
15.

Ginsenoside metabolites inhibit P-glycoprotein in vitro and in situ using three absorption models.

Li N, Wang D, Ge G, Wang X, Liu Y, Yang L.

Planta Med. 2014 Mar;80(4):290-6. doi: 10.1055/s-0033-1360334. Epub 2014 Feb 3.

PMID:
24493631
16.

Drug interactions with phytotherapeutics in oncology.

Haefeli WE, Carls A.

Expert Opin Drug Metab Toxicol. 2014 Mar;10(3):359-77. doi: 10.1517/17425255.2014.873786. Epub 2014 Jan 6. Review.

PMID:
24387348
17.

Ginseng treatment attenuates chronic cyclosporine nephropathy via reducing oxidative stress in an experimental mouse model.

Doh KC, Lim SW, Piao SG, Jin L, Heo SB, Zheng YF, Bae SK, Hwang GH, Min KI, Chung BH, Yang CW.

Am J Nephrol. 2013;37(5):421-33. doi: 10.1159/000349921. Epub 2013 Apr 10.

PMID:
23594788
18.

Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients.

Goey AK, Mooiman KD, Beijnen JH, Schellens JH, Meijerman I.

Cancer Treat Rev. 2013 Nov;39(7):773-83. doi: 10.1016/j.ctrv.2012.12.008. Epub 2013 Feb 8. Review.

PMID:
23394826
19.

Structure-inhibition relationship of ginsenosides towards UDP-glucuronosyltransferases (UGTs).

Fang ZZ, Cao YF, Hu CM, Hong M, Sun XY, Ge GB, Liu Y, Zhang YY, Yang L, Sun HZ.

Toxicol Appl Pharmacol. 2013 Mar 1;267(2):149-54. doi: 10.1016/j.taap.2012.12.019. Epub 2013 Jan 7.

PMID:
23306165
20.

Potential serious interactions between nutraceutical ginseng and warfarin in patients with ischemic stroke.

Shao J, Jia L.

Trends Pharmacol Sci. 2013 Feb;34(2):85-6. doi: 10.1016/j.tips.2012.11.008. Epub 2012 Dec 29. No abstract available.

PMID:
23277336

Supplemental Content

Loading ...
Support Center